David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Signet Jewelers
SIG
$3.16B
| $42.6M | 0.07% |
640,005
+551,919
| +627% | +$34M |
|
352
The Mosaic Company
MOS
$7.76B
| $42.5M | 0.07% |
1,967,521
+562,237
| +40% | +$12.2M |
|
353
VF Corp
VFC
$5.65B
| $42M | 0.06% |
701,959
+591,504
| +536% | +$34.1M |
|
|
FL
354
DELISTED
Foot Locker
FL
| $41.8M | 0.06% |
1,185,481
-231,371
| -16% | -$9.73M |
|
355
TE Connectivity
TEL
$58.9B
| $41.7M | 0.06% |
501,745
-303,347
| -38% | -$24.4M |
|
356
Steel Dynamics
STLD
$32.8B
| $41.7M | 0.06% |
1,208,392
-555,796
| -32% | -$19.5M |
|
|
POT
357
DELISTED
Potash Corp Of Saskatchewan
POT
| $41.5M | 0.06% |
2,152,526
+90,825
| +4% | +$1.62M |
|
358
PUT
Mettler-Toledo International
MTD
$28B
| $41.4M | 0.06% |
66,100
+15,000
| +29% | +$9.01M |
|
359
Ares Capital
ARCC
$14.3B
| $41.4M | 0.06% |
2,525,224
+324,158
| +15% | +$5.25M |
|
360
CALL
Biogen
BIIB
$32B
| $41.3M | 0.06% |
131,800
+31,700
| +32% | +$9.39M |
|
361
CVS Health
CVS
$119B
| $41.2M | 0.06% |
507,219
+268,095
| +112% | +$21.2M |
|
|
SWNC
362
DELISTED
Southwestern Energy Company
SWNC
| $41.2M | 0.06% |
2,945,000
+300,000
| +11% | +$4.11M |
|
363
Oracle
ORCL
$422B
| $41.1M | 0.06% |
849,104
+226,184
| +36% | +$11.3M |
|
364
Parker-Hannifin
PH
$126B
| $40.9M | 0.06% |
233,744
+199,487
| +582% | +$32.8M |
|
365
Entergy
ETR
$48.8B
| $40.4M | 0.06% |
1,057,088
+823,852
| +353% | +$31.9M |
|
366
Arista Networks
ANET
$238B
| $40.3M | 0.06% |
3,404,640
+1,446,016
| +74% | +$15.1M |
|
367
CALL
AT&T
T
$173B
| $40.3M | 0.06% |
1,362,793
+785,661
| +136% | +$22.3M |
|
368
CALL
JD.com
JD
$39.7B
| $40.2M | 0.06% |
1,052,800
+369,800
| +54% | +$15.8M |
|
369
Regeneron Pharmaceuticals
REGN
$85.9B
| $40.1M | 0.06% |
89,685
+29,937
| +50% | +$14.2M |
|
|
SPPI
370
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $40.1M | 0.06% |
2,849,168
+370,381
| +15% | +$3.35M |
|
371
Howmet Aerospace
HWM
$108B
| $40M | 0.06% |
2,097,043
+1,114,209
| +113% | +$21.3M |
|
372
JB Hunt Transport Services
JBHT
$25.9B
| $40M | 0.06% |
359,752
-414,719
| -54% | -$40.1M |
|
373
Cintas
CTAS
$81.6B
| $39.9M | 0.06% |
1,107,352
+932,916
| +535% | +$31.1M |
|
374
PUT
Target
TGT
$75.1B
| $39.6M | 0.06% |
670,300
+65,700
| +11% | +$3.68M |
|
375
Sally Beauty Holdings
SBH
$1.55B
| $39.5M | 0.06% |
2,018,755
+807,411
| +67% | +$15.9M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.